Lenalidomide

Lenalidomide

Parameter Technische Daten
Produktname Lenalidomide
CAS-Nummer 191732-72-6
Molekülformel C13H13N3O3
Molekulargewicht 259.26 g/mol
Aussehen Weißes bis cremefarbenes kristallines Pulver
Analyse (HPLC) ≥99.5%
Löslichkeit Sparingly soluble in DMSO, methanol; practically insoluble in water
Verpackung 25 kg fiber drum with double polyethylene bags

Brauchst du Hilfe? Kontaktieren Sie unser Team

Lenalidomide Structure

Synonyme: Lenalidomide, 191732-72-6, Revlimid, CC-5013, 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

Lenalidomide is a synthetic immunomodulatory imide drug (IMiD) and a potent analog of thalidomide. It is manufactured as a white to off-white crystalline powder with high purity, typically ≥99.5% by HPLC, and is supplied as a generic active pharmaceutical ingredient (API) for oncology and hematology applications. As a second-generation IMiD, it offers improved potency and a more favorable safety profile compared to its parent compound.

In the pharmaceutical industry, Lenalidomide is primarily used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Its dual mechanism of action—direct tumor cell apoptosis and modulation of the immune system—makes it a valuable component in combination therapies. The API is available in bulk quantities to support generic drug development and commercial production.

Product Highlights

  • High Purity: ≥99.5% assay by HPLC, with strict control of organic impurities.
  • Regulatory Support: Compliant with ICH guidelines; CEP and DMF available upon request.
  • Reliable Supply: Consistent manufacturing scale to meet commercial demand.
  • Dokumentation: Full set of COA, MSDS, and TDS provided with each shipment.
  • Quality Assurance: Produced in cGMP-certified facilities.

Applications & Formulation Use

  • Treatment of multiple myeloma (in combination with dexamethasone).
  • Management of myelodysplastic syndromes (MDS) with deletion 5q abnormality.
  • Mantle cell lymphoma after relapse or progression.
  • Research on immunomodulatory and anti-angiogenic pathways.

Quality Specifications (QC Tests)

Test Item Technische Daten
Identification IR, HPLC retention time conforms to reference standard
Trocknungsverlust ≤0,5%
Verbrennungsrückstand ≤0,1%
Schwermetalle ≤20 ppm
Organic Impurities Meet EP/USP requirements
Microbial Limits Total aerobic count ≤1000 CFU/g; Yeast & Mold ≤100 CFU/g

Bulk Supply & Ordering

  • Verpackung: 25 kg fiber drum with double polyethylene bags, or as per customer request.
  • Mindestbestellmenge: 1 kg for trial orders; 25 kg for commercial orders.
  • Lieferzeit: 3-5 business days for stock items.
  • Dokumentation: COA, MSDS, TDS, and regulatory support (CEP/DMF) available.

Häufig gestellte Fragen

What is the minimum order quantity (MOQ) for Lenalidomide?

Our MOQ is 1 kg for trial orders and 25 kg for commercial orders. For larger quantities, please contact us for a customized quote.

What is the delivery time?

For stock items, delivery is 3-5 business days after order confirmation. We ship globally via express or air freight.

Do you provide a Certificate of Analysis (COA) and samples?

Yes, a COA is provided with every shipment. Samples are available upon request for quality evaluation.

Contact & Ordering Information

  • Company: LyvBio Co., Ltd.
  • Address: Room 5-0203, Courtyard 205, Lianhu District, Xi’an, Shaanxi, China
  • Email: info@lyvbio.com
  • Phone: +86-29-65816888

send us your specification for a quotation.

BLEIBEN SIE IN KONTAKT

Angebotsanfrage

Unsere Adresse

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×